Early detection of lung cancer may now be possible with a new blood test that analyzes free-floating DNA in the blood, according to the Dana-Farber Cancer Institute.
"We're excited that the initial results from the CCGA study show it is possible to detect early-stage lung cancer from blood samples using genome sequencing," said lead study author Geoffrey R. Oxnard, MD, of Dana-Farber Cancer Institute. "There is an unmet need globally for early-detection tests for lung cancer that can be easily implemented by health-care systems....
Early detection of lung cancer may now be possible with a new blood test that analyzes free-floating DNA in the blood, according to the Dana-Farber Cancer Institute.
"We're excited that the initial results from the CCGA study show it is possible to detect early-stage lung cancer from blood samples using genome sequencing," said lead study author Geoffrey R. Oxnard, MD, of Dana-Farber Cancer Institute. "There is an unmet need globally for early-detection tests for lung cancer that can be easily implemented by health-care systems....